These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. ARISTOLOCHIC ACID (NSC-50413): PHASE I CLINICAL STUDY. JACKSON L; KOFMAN S; WEISS A; BRODOVSKY H Cancer Chemother Rep; 1964 Nov; 42():35-7. PubMed ID: 14226128 [No Abstract] [Full Text] [Related]
45. [TREATMENT PROCEDURE IN ONCOLYTIC CHEMOTHERAPY WITH 5-FLUOROURACIL]. DELMON G Presse Med (1893); 1964 May; 72():1309-10. PubMed ID: 14132923 [No Abstract] [Full Text] [Related]
46. [STUDIES ON CONTINUOUS INTRA-HYPOGASTRIC ARTERIAL INFUSION OF ANTICARCINOGENIC AGENTS IN PATIENTS WITH CERVICAL CANCER AS A SUPPLEMENTARY THERAPY TO SURGICAL OPERATION]. IZUCHI S Gan No Rinsho; 1964 Sep; 10():689-96. PubMed ID: 14209132 [No Abstract] [Full Text] [Related]
47. CLOSED PELVIC PERFUSION: ISOLATION PERFUSION OF THE PELVIS WITHOUT CELIOTOMY. MARTIN DS; WHITE HM; HOBBS J; KURZWEG FT; HUDSON PJ Surgery; 1964 Dec; 56():1056-63. PubMed ID: 14238359 [No Abstract] [Full Text] [Related]
48. [USE OF 5-FLUOROURACIL IN CLINICAL MALIGNANT TUMORS]. BLOKHINA NG Vestn Akad Med Nauk SSSR; 1964; 19():62-6. PubMed ID: 14319661 [No Abstract] [Full Text] [Related]
49. A COMPARISON OF THE EFFECTS OF SELECTED CYTOTOXIC AGENTS ON THE PRIMARY AGGLUTININ RESPONSE IN RATS INJECTED WITH SHEEP ERYTHROCYTES. SANTOS GW; OWENS AH Bull Johns Hopkins Hosp; 1964 Jun; 114():384-401. PubMed ID: 14169465 [No Abstract] [Full Text] [Related]
50. [HEMATOLOGIC OBSERVATIONS DEDUCED FROM THE SYSTEMATIC CONTROL OF 300 TERMINAL CANCER PATIENTS SUBJECTED TO ANTIMITOTIC TREATMENT]. JUANYMARCOS A; ESPINOSA JA Med Esp; 1964 Nov; 52():383-97. PubMed ID: 14283792 [No Abstract] [Full Text] [Related]
52. RADIATION AND DRUG INDUCED HYALINIZATION OF THE STOMACH. SMITH JC; BOLANDE RP Arch Pathol; 1965 Mar; 79():310-6. PubMed ID: 14246210 [No Abstract] [Full Text] [Related]
55. BLOOD AND URINE LEVELS OF ANTITUMOR AGENTS DETERMINED WITH CELL CULTURE METHODS. SMITH CG; GRADY JE; KUPIECKI FP Cancer Res; 1965 Feb; 25():241-5. PubMed ID: 14264057 [No Abstract] [Full Text] [Related]
56. DOSE-RESPONSE RELATIONSHIPS FOR AGENTS INHIBITING THE IMMUNE RESPONSE. BERENBAUM MC; BROWN IN Immunology; 1964 Jan; 7(1):65-71. PubMed ID: 14113077 [TBL] [Abstract][Full Text] [Related]
57. [TREATMENT OF SOLID MALIGNANT TUMORS IN CHILDREN WITH VINCRISTINE SULFATE]. SILVASOSA M Bol Med Hosp Infant Mex; 1965; 22():169-80. PubMed ID: 14321208 [No Abstract] [Full Text] [Related]
58. AZETEPA (NSC-64826) IN STAGE IV BREAST CANCER. FALKSON G; FALKSON HC Cancer Chemother Rep; 1964 Dec; 43():19-24. PubMed ID: 14250646 [No Abstract] [Full Text] [Related]
59. COMBINED SPLIT-COURSE THERAPY WITH 5-FLUOROURACIL AND MEGAVOLTAGE IRRADIATION. HOLSTI LR Ann Med Intern Fenn; 1964; 53():79-87. PubMed ID: 14233847 [No Abstract] [Full Text] [Related]
60. INTRA-ARTERIAL ADMINISTRATION OF 2-ETHYLHYDRAZIDE OF PODOPHYLLIC ACID (NSC-72274) IN LOCALIZED MALIGNANT DISEASE. NEWTON KA; WESTBURY G; WHITE WF Cancer Chemother Rep; 1964 Dec; 43():33-8. PubMed ID: 14250650 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]